10.6084/m9.figshare.4542913.v1
Lim D.J.
Lim
D.J.
Kim W.B.
Kim
W.B.
Kim B.H.
Kim
B.H.
Kim T.Y.
Kim
T.Y.
Jo Y.S.
Jo
Y.S.
Kang H.-C.
Kang
H.-C.
Park Y.J.
Park
Y.J.
Yi K.H.
Yi
K.H.
Shong M.
Shong
M.
Kim I.J.
Kim
I.J.
Park D.J.
Park
D.J.
Kim S.W.
Kim
S.W.
Chung J.H.
Chung
J.H.
Lee J.
Lee
J.
Koong S.-S.
Koong
S.-S.
Shong Y.K.
Shong
Y.K.
Supplementary Material for: Differences in Physicians' and Patients' Perception of Acute Hypothyroid Symptoms Induced by Thyroid Hormone Withdrawal in Thyroid Cancer Patients: A Multicenter Survey in Korea
Karger Publishers
2017
Thyroid cancer
Hypothyroidism
Symptoms
Physicians’ practice patterns
Patients
2017-01-12 14:20:27
Dataset
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Differences_in_Physicians_and_Patients_Perception_of_Acute_Hypothyroid_Symptoms_Induced_by_Thyroid_Hormone_Withdrawal_in_Thyroid_Cancer_Patients_A_Multicenter_Survey_in_Korea/4542913
<p><b><i>Background:</i></b> Acute short-term hypothyroidism induced by
thyroid hormone withdrawal (THW) for follow-up surveillance or
therapeutic radioiodine causes patients with differentiated thyroid
cancer to suffer from a myriad of deleterious symptoms. <b><i>Objectives:</i></b> To know how patient recognition of hypothyroid symptoms compares to physician perception of patient symptoms. <b><i>Methods:</i></b>
The survey was performed in 10 referral hospitals throughout Korea from
December 2010 to May 2011 and targeted patients with total
thyroidectomy and remnant ablation. The survey consisted of questions
regarding the effect of THW on patient symptoms, the duration of
symptoms, impact on social life, and patient complaints. The physicians
treating thyroid cancer patients also responded to the survey and
provided their perceptions of patient symptoms and treatment decisions. <b><i>Results:</i></b>
About 70% of the patients responded that they experienced a negative
physical or psychological impact on their life and work due to
hypothyroid symptoms. However, 76% of doctors thought hypothyroidism
could negatively impact a patient's daily life but would be endurable.
Two thirds of physicians do not routinely recommend recombinant human
TSH (rhTSH) to their patients. Multivariate analysis showed patients
with female sex, stronger educational background, emotionally negative
experiences of hypothyroidism, and younger age were more willing to pay
for therapy that could prevent hypothyroidism symptoms. <b><i>Conclusions:</i></b>
There was a substantial gap in the perception of hypothyroid symptoms
during THW between physicians and patients. Physicians who are aware of
the seriousness of hypothyroidism in their patients were more likely to
recommend the use of rhTSH for their patients.</p>